It is reported that inhibiting WRN is a potential strategy for microsatellite instability (MSI) cancer therapy.[6a,c] Precise evaluation of WRN inhibitory efficiency in living cells might be promising for WRN inhibitor development. This evidence concerns the gene WRN and cancer.